Hint mode is switched on Switch off
For swift navigation between sections

Santhera Pharmaceuticals
LEI 54930035HAOFTTQH0U85

PDF download

Choose all Reset all
Download Cancel
Organization name
Santhera Pharmaceuticals Holding AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Santhera Pharmaceuticals is a Swiss drug discovery and development company. It is focused on the development of treatments for neuromuscular and neuro-ophthalmological diseases that currently lack treatment options. The company was founded in 2004 through the merger of two start-up biotech companies, MyoContract and Graffinity Pharmaceuticals. Santhera’s headquarters are located in Liestal, Switzerland, with subsidiaries in Germany, UK, Italy, Netherlands, Liechtenstein, US and Canada.

Awards

Documentation

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    54930035HAOFTTQH0U85
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • UID
    CHE105388338
Registration is required to get access.